Digest Network Come funziona
Network
/
Società
Ti
Non verificato

Tiziana Life Sciences Ltd.

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaFondi di investimentoMedicina Salute Benessere

23 comunicati stampa

Guarda tutti i comunicati
16/10/2026
Biotecnologia
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
30/09/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
28/09/2026
Biotecnologia
Annunci Economici
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
21/09/2026
Biotecnologia
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
17/09/2026
Biotecnologia
Medicina Salute Benessere
Management/Organizzazione Aziendale
Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
24/08/2026
Biotecnologia
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
06/08/2026
Biotecnologia
Medicina Salute Benessere
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
04/08/2026
Biotecnologia
Finanza
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
31/07/2026
Biotecnologia
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0
22/07/2026
Biotecnologia
Finanza
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Fonte
Tiziana Life Sciences Ltd.
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0